Bio4t2 announces first patient infused with CAR-T targeting solid tumors ...Middle East

SAN DIEGO, Jan. 10, 2023 /PRNewswire/ -- Bio4t2 dosed the first patient with T cells bearing a chimeric antigen receptor (CAR) that targets overexpression of BT-001 antigen present on various types of solid tumors. The CAR-T (B4t2-001) was developed from Bio4t2's PrismCore™ platform....

Hence then, the article about bio4t2 announces first patient infused with car t targeting solid tumors was published today ( Tuesday 10/01/2023 - 10:08 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Bio4t2 announces first patient infused with CAR-T targeting solid tumors )

Also on site :

• Cyberattack hits Canvas system used by thousands of schools as finals loom
• Leak points to insider who allegedly helped Zelensky crony escape justice – media
• Philadelphia Soccer 2026 otvára akreditácie médií a registráciu fanúšikov na festival fanúšikov FIFA Fan Festival™ vo Philadelphii